These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31512783)
1. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model. Fan X; Bjerke GA; Riemondy K; Wang L; Yi R Mol Carcinog; 2019 Dec; 58(12):2241-2253. PubMed ID: 31512783 [TBL] [Abstract][Full Text] [Related]
2. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence. Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312 [TBL] [Abstract][Full Text] [Related]
3. DGCR8 is essential for tumor progression following PTEN loss in the prostate. Belair CD; Paikari A; Moltzahn F; Shenoy A; Yau C; Dall'Era M; Simko J; Benz C; Blelloch R EMBO Rep; 2015 Sep; 16(9):1219-32. PubMed ID: 26206718 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer. Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912 [TBL] [Abstract][Full Text] [Related]
5. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway. Zhang Y; Zhang D; Lv J; Wang S; Zhang Q Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630 [TBL] [Abstract][Full Text] [Related]
6. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice. Lu TL; Huang YF; You LR; Chao NC; Su FY; Chang JL; Chen CM Am J Pathol; 2013 Mar; 182(3):975-91. PubMed ID: 23313138 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Wu Z; He B; He J; Mao X Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044 [TBL] [Abstract][Full Text] [Related]
8. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways. Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963 [TBL] [Abstract][Full Text] [Related]
10. LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis. Yu EJ; Hooker E; Johnson DT; Kwak MK; Zou K; Luong R; He Y; Sun Z PLoS One; 2017; 12(3):e0174357. PubMed ID: 28323888 [TBL] [Abstract][Full Text] [Related]
11. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate. Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
13. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Thomsen MK; Ambroisine L; Wynn S; Cheah KS; Foster CS; Fisher G; Berney DM; Møller H; Reuter VE; Scardino P; Cuzick J; Ragavan N; Singh PB; Martin FL; Butler CM; Cooper CS; Swain A; Cancer Res; 2010 Feb; 70(3):979-87. PubMed ID: 20103652 [TBL] [Abstract][Full Text] [Related]
14. Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro. Tian L; Fang YX; Xue JL; Chen JZ PLoS One; 2013; 8(9):e75885. PubMed ID: 24098737 [TBL] [Abstract][Full Text] [Related]
15. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition. Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007 [TBL] [Abstract][Full Text] [Related]
16. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors. Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230 [TBL] [Abstract][Full Text] [Related]
17. β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma. Francis JC; Thomsen MK; Taketo MM; Swain A PLoS Genet; 2013; 9(1):e1003180. PubMed ID: 23300485 [TBL] [Abstract][Full Text] [Related]
18. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465 [TBL] [Abstract][Full Text] [Related]
19. miR-21: an oncomir on strike in prostate cancer. Folini M; Gandellini P; Longoni N; Profumo V; Callari M; Pennati M; Colecchia M; Supino R; Veneroni S; Salvioni R; Valdagni R; Daidone MG; Zaffaroni N Mol Cancer; 2010 Jan; 9():12. PubMed ID: 20092645 [TBL] [Abstract][Full Text] [Related]
20. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]